Table of Content - Insulin Sensitizers Market

Insulin sensitizers are medications that improve insulin sensitivity and reduce blood sugar levels. These are also known as blood sugar normalizing agents and euglycemics, and these help in returning blood glucose to the normal range without using insulin. These work by increasing liver, muscle and fat cells' sensitivity to insulin. There are several different types of insulin sensitizers including metformin (Met), pioglitazone (Pio), thiazolidinediones (TZDs), and inositols.

Market Dynamics

Global insulin sensitizers market growth is driven by increased prevalence of diabetes, especially type 2 diabetes. Insulin sensitizers are frequently used to increase insulin sensitivity and manage blood glucose levels in the treatment of type 2 diabetes. Type 2 diabetes and insulin resistance are both significantly increased by obesity. Effective insulin sensitizer helps in controlling insulin resistance and related metabolic diseases due to rising prevalence of obesity worldwide. The ongoing research and development activities have introduced new and enhanced insulin sensitizers that creates innovative compounds and formulation methods, and improves the efficacy and safety profiles of drugs that treat insulin sensitivity. Furthermore, the governments have taken several initiatives to combat diabetes. The plans and the programs focus on spreading knowledge about diabetes, early detection of diabetes and facilitating necessary and affordable treatments like insulin sensitizers.

Like any drugs, insulin sensitizers have potential side effects like weight gain, fluid retention, bone fractures, and an elevated risk of heart failure. Specific kinds of insulin sensitizers such as thiazolidinediones (TZDs) may create worries about its safety concern, thus, restricting their use and make them difficult to embrace widely.

Key features of the study:

This report provides in-depth analysis of the global insulin sensitizers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global insulin sensitizers market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Eli Lilly and Company, Novo Nordisk, Sanofi, Merck & Co., Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Takeda Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global insulin sensitizers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insulin sensitizers market

Insulin Sensitizers Market Detailed Segmentation:

By Type:
- Thiazolidinediones (TZDs)
- Biguanides
- Incretin-based therapies
- Others
By Indication:
- Type 2 Diabetes
- Prediabetes
- Polycystic Ovary Syndrome (PCOS)
By Route of Administration:
- Oral
- Injectable
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
Company Profiles:
- Eli Lilly and Company
- Novo Nordisk
- Sanofi
- Merck & Co.
- Bristol Myers Squibb
- AstraZeneca
- Boehringer Ingelheim
- Johnson & Johnson
- Takeda Pharmaceutical

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Insulin Sensitizers
  - Market Snippet, By Indication
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Increasing prevalence of diabetes
    - Growing global obesity epidemic
    - Advancements in drug development
    - Favorable government initiatives
  - Restraints
    - Adverse effects and safety concerns
    - Limited efficacy in certain patient populations
    - Regulatory challenges and market access
  - Opportunities
    - Emerging economies
    - Personalized medicine
    - Combination therapies
    - Non-diabetic applications
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Insulin Sensitizers Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Insulin Sensitizers Market, By Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Thiazolidinediones (TZDs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Biguanides
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Incretin-based therapies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Insulin Sensitizers Market, By Indication, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Type 2 Diabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn )
- Prediabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Polycystic Ovary Syndrome (PCOS)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Insulin Sensitizers Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Insulin Sensitizers Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Insulin Sensitizers Market, By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Region, 2019 –2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East & Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - GCC
    - Israel
    - North Africa
    - Central Africa
    - Rest of Middle East & Africa
Competitive Landscape
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novo Nordisk
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 44 market data tables and 36 figures on "Global Insulin Sensitizers Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount